Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEG vs aPTT for Anticoagulation Monitoring in ECMO
NCT02271126Phase 1Completed
- Sponsor
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
- Start
- Sep 2014
- Primary completion
- Sep 2016
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial (2 arms), sponsored by Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico. Primary endpoints: Safety at 2 years and Feasibility at 2 years. Started Sep 2014; status: completed.
Beyond the preview
Go deeper on NCT02271126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02271126.